Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• Stifel on COMPASS Pathways plc (CMPS): 'COMP360 continues to be well-tolerated'
• American Eagle Outfitters (AEO) call put ratio 3.1 calls to 1 put with a focus on September 15 and 17 calls into quarter results